[1]
“Surrogate Parameters, Instead of the Genetic Profile, for Recurrence Risk Evaluation in #x201C;Early-Stage Breast Cancer Cases#x201D; in a Middle #x2013; Income Country like Argentina”, GJMR, vol. 22, no. F3, pp. 27–33, Mar. 2022, Accessed: Mar. 11, 2026. [Online]. Available: https://medicalresearchjournal.org/index.php/GJMR/article/view/2666